Company Filing History:
Years Active: 2014-2021
Title: Efraim Shek: Innovator in Amantadine Administration
Introduction
Efraim Shek is a notable inventor based in Pleasanton, CA, who has made significant contributions to the field of pharmaceutical administration. With a total of six patents to his name, Shek has focused on improving the methods of administering amantadine, particularly in relation to sleep disturbances.
Latest Patents
Among his latest patents is a method of administering amantadine prior to a sleep period. This patent describes methods of nighttime administration of amantadine to reduce sleep disturbances in patients undergoing treatment with the drug. Additionally, it includes compositions of extended-release amantadine that are suitable for nighttime administration, enhancing the effectiveness of the treatment.
Career Highlights
Efraim Shek has worked with prominent companies in the pharmaceutical industry, including Adamas Pharma, LLC and Adamas Pharmaceuticals, Inc. His work has been instrumental in developing innovative solutions for patients requiring amantadine treatment.
Collaborations
Throughout his career, Shek has collaborated with notable professionals in the field, including Gregory T. Went and Gayatri Sathyan. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Efraim Shek's contributions to the administration of amantadine have paved the way for improved patient care and treatment outcomes. His innovative methods and dedication to research continue to impact the pharmaceutical industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.